Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
20 June 2016 |
Main ID: |
NCT01603199 |
Date of registration:
|
17/05/2012 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis
|
Scientific title:
|
Impact of a High-protein High-fiber Diet on the Nutritional Status of Patients With Primary Biliary Cirrhosis |
Date of first enrolment:
|
September 2011 |
Target sample size:
|
36 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT01603199 |
Study type:
|
Interventional |
Study design:
|
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Mexico
| | | | | | | |
Contacts
|
Name:
|
Aldo Torre Delgadillo, M.D. M.Sc |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
INCMNSZ |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Controls
Diagnose of primary biliary cirrhosis:
- Biochemical evidence of cholestasis: based mainly on alkaline phosphatase elevation
- Presence of antimitochondrial antibodies (AMA)
- Histologic evidence of nonsuppurative destructive cholangitis and destruction of
interlobular bile ducts.
Ambulatory patients
- Cases
Diagnose of primary biliary cirrhosis:
- Biochemical evidence of cholestasis: based mainly on alkaline phosphatase elevation
- Presence of antimitochondrial antibodies (AMA)
- Histologic evidence of nonsuppurative destructive cholangitis and destruction of
interlobular bile ducts.
Diagnose of liver cirrhosis by two or more of the following criteria:
- Albumin < 3.4 g/dL
- INR = 1.3
- Total bilirubin = 2 mg/dL
- Portal hypertension (esophageal varices, splenomegaly, ascites, etc.)
- Liver biopsy Ambulatory patients
Exclusion Criteria:
- Overlapping syndrome with predominant autoimmune hepatitis
- Hospitalized patients
- Acute or chronic renal failure
- Hepatocellular carcinoma
- Pregnancy
- Neuropsychiatric disorders (Schizophrenia, bipolar disorder, dementia and
attention-deficit hyperactivity disorder)
Age minimum:
18 Years
Age maximum:
70 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Primary Biliary Cirrhosis
|
Intervention(s)
|
Dietary Supplement: High protein high fiber diet
|
Primary Outcome(s)
|
Nutritional status
[Time Frame: Participants will be followed for 6 months]
|
Secondary Outcome(s)
|
Quality of life
[Time Frame: Participants will be followed for 6 months]
|
Minimal hepatic encephalopathy
[Time Frame: Participants will be followed for 6 months]
|
Secondary ID(s)
|
GAS-460-11/12-1
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|